Log In
Print
BCIQ
Print
Print this Print this
 

AYX1

  Manage Alerts
Collapse Summary General Information
Company Adynxx Inc.
DescriptionSmall synthetic dsDNA inhibitor of early growth response 1 (EGR1)
Molecular Target Early growth response 1 (EGR1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsPrevent acute and chronic post-surgical pain; Prevent chronic pain; Prevent postoperative pain
Regulatory Designation U.S. - Fast Track (Prevent chronic pain)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today